Search

everythinglearnresearchcommunity

for

Search:↓

Morroniside has many health benefits, including protection against diabetes complications, bone and brain diseases, heart and skin issues, and it supports hair growth and reduces inflammation.

Liposomal carriers can improve tissue regeneration by stabilizing and retaining growth factors.

Stem cells from umbilical cord blood may prevent hair loss caused by certain medications.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Short telomeres contribute to aging and cancer, and while telomerase can delay aging, it may also promote cancer.

DHT affects bone growth by altering gene activity in osteoblasts, potentially complicating steroid use.

Quercetin significantly helps hair growth by activating hair follicles and improving blood vessel formation around them.

New antiscarring strategies show promise, including drugs, stem cells, and improved surgical techniques.

PRP may improve fertility treatment success but needs more research for safe use.

Hair follicle stem cells from aged eyelid skin can become corneal endothelial-like cells for potential eye treatments.

Mitochondrial therapy and platelet-rich plasma therapy both stimulated hair regrowth in aging mice, with mitochondrial therapy showing similar effectiveness to plasma therapy.

IGF-1, KGF, and stem cells help skin cells move and survive, potentially speeding up wound healing.

LLLT helps treat hair loss by increasing blood flow, reducing inflammation, and stimulating growth factors.

Two women were diagnosed with a rare melanoma that looked like hair loss but was actually a type of skin cancer.

Melatonin treatment helps improve skin health in postmenopausal rats.

Angio PRP speeds up skin wound healing and reduces inflammation.

Electrospun scaffolds can improve healing in diabetic wounds.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

Platelet-rich fibrin shows promise for treating oral lesions but needs more research.

New treatments targeting T-cell pathways are needed for better alopecia areata management.

Conditioned media from mesenchymal stem cells show promise for tissue repair and disease treatment, but more research is needed on their safety and effectiveness.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

PRP is not a stem cell treatment and should not be marketed as such.

PCOS symptoms vary by age, affecting diagnosis and treatment.

The document reports findings on genetic research, including ethical concerns about genome editing, improved diagnosis of mitochondrial mutations, solving inherited eye diseases, confirming gene roles in epilepsy, linking a gene to aneurysms, and identifying genes associated with age-related macular degeneration.

Erdr1 could be a new marker for diagnosing hair loss.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Gray hair can potentially be reversed, leading to new treatments.

Total glucosides of paeony can help treat skin conditions but need more research for clinical use.

Activating TLR5 in the gut can extend lifespan and improve health in aged mice.